Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on September 29, 2026

Sep. 29, 2026

Rx Credentialing Achieves Elite 5-Star Ranking for Medical Billing, Credentialing, and Virtual Assistant Services

Indeterminate EIN Presswire

Sep. 29, 2026

Bellwether Innovation Campus EB-5 Project Receives USCIS Form I-956F Approval

Indeterminate EIN Presswire

Sep. 29, 2026

Singapore Stroke Survivor Terence Ang Marks World Stroke Day 2026 With a Month of Global Advocacy, Art and Storytelling

Indeterminate EIN Presswire

Sep. 29, 2026

Stephen Shaya, M.D. Receives 2026 Agent of Change Award at the United Nations During UN General Assembly

Indeterminate EIN Presswire

Sep. 29, 2026

Gentle Steps Licensed Behavior Analysis PLLC Becomes a Certified Autism Center™, Expanding Accessible Care

Indeterminate EIN Presswire

Sep. 29, 2026

DOMINANT ANIMALS - A HISPANIC HERITAGE MONTH EVENT IN NYC

Indeterminate EIN Presswire

Sep. 29, 2026

As Kids Return to School With AI in Their Toolkit, AirDroid Helps Parents Stay Alert to Risky AI Conversations

Indeterminate EIN Presswire

Sep. 29, 2026

Nine Months Old, a Heart Defect and No Explanation, Until a Dante Labs Whole Genome Identified Amira's CHARGE Syndrome

Indeterminate EIN Presswire

Sep. 29, 2026

DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

Indeterminate GlobeNewswire

Sep. 29, 2026

DBV Technologies annonce le dépôt de sa demande de licence biologique (BLA) auprès de la Food and Drug Administration des Etats-Unis pour le patch VIASKIN® Peanut destiné aux enfants âgés de 4 à 7 ans.

Indeterminate GlobeNewswire

Sep. 29, 2026

Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology

Indeterminate GlobeNewswire

Sep. 29, 2026

Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

Sep. 29, 2026

HL7 Launches Break the Code to Build the Next Generation of Healthcare Interoperability Talent

Indeterminate GlobeNewswire

Sep. 29, 2026

CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

Pyxis Oncology Announces Proposed Public Offering

Indeterminate GlobeNewswire

Sep. 29, 2026

Vireo Growth Inc. Announces Put/Call Agreement in Connection with Loan Acquisition

Indeterminate GlobeNewswire

Sep. 29, 2026

Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer

Indeterminate GlobeNewswire

Sep. 29, 2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 29, 2026

Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)

Indeterminate GlobeNewswire

Sep. 29, 2026

Equillium Announces Poster Presentations at the 7th International AHR Conference

Indeterminate GlobeNewswire